Soumya Chatterjee

Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist

J H Korn, Maureen D. Mayes, M Matucci Cerinic et al. · Arthritis & Rheumatism · 2004 · 720 citations

Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts

Frank C. Arnett, Mimi Cho, Soumya Chatterjee et al. · Arthritis & Rheumatism · 2001 · 288 citations

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase <scp>II</scp> Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial

Dinesh Khanna, Cathie Spino, Sindhu R. Johnson et al. · Arthritis & Rheumatology · 2019 · 218 citations · Full text

Risk of malignancy in scleroderma: A population‐based cohort study

Soumya Chatterjee, George W. Dombi, Richard K. Severson et al. · Arthritis & Rheumatism · 2005 · 131 citations

A multicenter, randomized, double‐blind, placebo‐controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. Oral type I collagen does not improve skin in all patients, but may improve skin in late‐phase disease

Arnold E. Postlethwaite, Weng Kee Wong, Philip J. Clements et al. · Arthritis & Rheumatism · 2008 · 113 citations · Full text